🔎 Trials Near Me

Nyumbani › Limfoma › Ohio › Cleveland

Majaribio ya kliniki ya Limfoma katika Cleveland, OH

Masomo 14 ya Limfoma yanatafuta washiriki katika vituo vya Cleveland na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

InaajiriHatua 1/2
  • University Hospitals Seidman Cancer Center, Cleveland
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06343311

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

InaajiriHatua 1
  • University Hospitals Cleveland Medical Center, Cleveland
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07192471

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

InaajiriHatua 2
  • Cleveland Clinic, Cleveland
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07015242

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

InaajiriHatua 2
  • University Hospitals Cleveland Medical Center, Cleveland
1 Month – 17 Years · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT04570423

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

InaajiriHatua 2
  • The Cleveland Clinic Foundation, Cleveland
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Sep 2026 · NCT07221500

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

InaajiriHatua 1/2
  • Cleveland Clinic, Cleveland
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT05826535

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

InaajiriHatua 1/2
  • Cleveland Clinic, Cleveland
Umri 12 na zaidi · Jinsia zote · Imesasishwa 20 Ago 2026 · NCT06678659

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

InaajiriHatua 3
  • Cleveland Clinical Taussig Cancer Center, Cleveland
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Ago 2026 · NCT07188558

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

InaajiriHatua 1
  • University Hospitals Cleveland Medical Center, Cleveland
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Jul 2026 · NCT07465835

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

InaajiriHatua 1
  • Cleveland Clinic, Cleveland
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Jul 2026 · NCT05131022

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

InaajiriHatua 1/2
  • Cleveland Clinic, Cleveland
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Apr 2026 · NCT03328078

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
  • Cleveland Clinic, Cleveland
Umri 40 na zaidi · Jinsia zote · Imesasishwa 20 Jan 2026 · NCT05366881

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

InaajiriHatua 1
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Nov 2025 · NCT06916767

Majaribio ya Limfoma katika miji mingine

Masomo mengine katika Cleveland

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.